HDAC4 inhibition disrupts TET2 function in high-risk MDS and AML

Huang, FT; Sun, J; Chen, W; He, X; Zhu, YH; Dong, HJ; Wang, HY; Li, Z; Zhang, L; Khaled, S; Marcucci, G; Huang, JW; Li, L

Huang, JW (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Hematol, Hangzhou 310016, Peoples R China.; Li, L (corresponding author), City Hope Med Ctr, Dept Hematol Malignancies Translat Sci, Hematol Malignancies & Stem Cell Transplantat Ins, Beckman Res Inst,Gehr Family Ctr Leukemia Res, Duarte, CA 91010 USA.

AGING-US, 2020; 12 (17): 16759